Patients with DYSF mutations typically showed a later disease onset, the highest CK levels, and occasionally respiratory involvement, though none exhibited cardiac disease—again mirroring typical dysferlinopathy features [28,29,30]. The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.